Phytomem One has launched a dietary supplement tablet containing ten active ingredients, including Saffron Extract and Berberine HCl, aimed at cognitive support and addressing microplastic exposure.
BOISE, Idaho, September 12, 2026 — Phytomem One has disclosed all ten active ingredients in a new dietary supplement tablet, presenting each compound individually rather than grouping them into an undisclosed proprietary blend: Saffron Extract, Fucoxanthin, Fucoidan, Oleuropein, Berberine HCl, Ceylon Cinnamon Bark, Corosolic Acid, Kudzu Flower Extract, Morosil, and Xylitol. The product is manufactured in a USDA National Organic Program-certified facility and distributed through ClickBank, an e-commerce platform operated by Click Sales, Inc., a Delaware corporation. The intended use is once-daily adult supplementation.
“Phytomem One was formulated around published research on individual botanical and nutritional compounds. The ingredients were selected based on their independently studied properties. We make no claim that this formula replicates the outcomes of any independent study on these compounds,” said Payton Williamson, Media Relations at Phytomem One.
What Phytomem One Is
Phytomem One is launched as a dietary supplement, not a medication or treatment for any diagnosed condition. It is marketed as part of a balanced lifestyle, rather than as a standalone solution or substitute for medical treatment. The company describes the product as non-GMO and stimulant-free; this release has not independently verified these characterizations against current product documentation.
The product launch coincides with recent peer-reviewed publication in two areas relevant to the formula’s ingredient categories. A 2025 study published in Nature Medicine (Nihart et al., doi:10.1038/s41591-024-03453-1) documented measurable microplastic particle accumulation in postmortem human brain tissue samples — the first peer-reviewed confirmation of microplastic bioaccumulation specifically in human brain tissue at that scale. Separately, a randomized controlled trial published in the Journal of Clinical Endocrinology & Metabolism (Zhang et al., 2008, doi:10.1210/jc.2007-2339) examined berberine — one of the formula’s ten disclosed ingredients — in adult subjects over three months, measuring effects on blood glucose and lipid metabolism markers. Neither study tested the Phytomem One product, and neither establishes that this formula produces equivalent outcomes. No dietary supplement has received FDA approval for the treatment, prevention, or mitigation of any condition.
“When formulating Phytomem One, our priority was complete label transparency rather than hiding behind proprietary blends,” said Payton Williamson, Media Relations at Phytomem One. “By disclosing all ten active ingredients individually, we give adults and their physicians the information needed to make informed decisions about whether this product is appropriate for them.”
The Ten-Ingredient Formula
Saffron Extract (Crocus sativus L.) has an independent peer-reviewed research base. A review in the Journal of Integrative Medicine (Tóth et al., 2019, doi:10.1016/j.joim.2019.09.009) examined saffron supplementation across multiple trials in adult subjects. The specific citations referenced by the company in its marketing materials were not independently retrieved or verified for this release.
Fucoxanthin, derived from Japanese Sea Kelp, has been examined in preclinical and limited human research. The human evidence base remains limited; specific publication claims referenced by the company were not independently retrieved for this release.
Fucoidan, also derived from Japanese Sea Kelp, has been examined in preclinical research settings. Specific claims made by the company in its marketing materials were not independently attributed to a published human clinical trial by this release; consumers should request underlying citations directly from the manufacturer.
Oleuropein from Olive Leaf Extract has been examined in published literature in preclinical and limited human research settings. Specific effect claims made by the company were not independently verified for this release.
Berberine HCl is a plant compound with a clinical research base examining blood glucose and lipid metabolism markers in adult subjects (Zhang et al., 2008, Metabolism, doi:10.1016/j.metabol.2008.01.013). It is pharmacologically active in a way the formula’s other nine ingredients are not: berberine has documented interactions with diabetes medications and with blood thinners. This is the single most important safety consideration in the Phytomem One formula and should not be treated as equivalent to cautions for the other nine ingredients.
Ceylon Cinnamon Bark (Cinnamomum verum) has been examined in published research in adult subjects. Specific claims cited by the company were not independently verified for this release; consumers should request underlying citations from the manufacturer.
Corosolic Acid from Banaba Leaf has been examined in limited human research. The published evidence base for this compound is smaller than that of berberine.
Kudzu Flower Extract contains isoflavones that have been examined in published research. The specific institutional citation referenced by the company was not independently retrieved for this release and should be treated as a company representation.
Morosil, a red orange fruit extract, has been examined in a small number of published studies. The company’s claims regarding its effects on other formula ingredients represent formulation-level claims that were not independently verified for this release.
Xylitol is a sugar alcohol included as a carbohydrate source. Its specific role as described in the company’s marketing materials represents a formulation claim.
How the Formula Is Positioned to Work Together
The company groups its ten ingredients into three internal categories. This grouping reflects the company’s formulation rationale rather than established pharmacological classifications. The company has not published or cited a clinical trial testing the ten-ingredient combination as a single finished product.
Market Context
The figures below are sourced from third-party market research and are not claims made by Phytomem One regarding its own commercial performance. According to Grand View Research’s Brain Health Supplements Market Size, Share & Trends Analysis Report (grandviewresearch.com, 2023), the global brain health supplement market was valued at approximately $8.3 billion in 2023 and is projected to reach $33.6 billion by 2030. This figure describes the broader market category and is not evidence supporting any claim specific to this product’s formula or effectiveness.
Published scientific literature has documented the detection of microplastic particles in human tissue samples (Nihart et al., 2025, Nature Medicine, doi:10.1038/s41591-024-03453-1). Whether dietary supplement ingredients can address microplastic-related processes is not established by published clinical evidence; the company references a documented scientific finding in connection with its product without clinical evidence linking the two.
Safety Considerations
Berberine HCl can interact with diabetes medications and blood thinners. It is not recommended without medical guidance for anyone who is pregnant, nursing, or managing a blood glucose-related condition. Individuals taking prescription glucose-lowering medications should not adjust their medication based on supplement use without physician guidance. This reflects a documented drug interaction risk.
Kudzu Flower Extract contains plant compounds that may have activity relevant to individuals with certain health conditions; those individuals should consult a physician before use. Anyone with an existing medical condition or taking prescription medication should consult a physician before use. This product is not intended for use by anyone under 18.
Manufacturing Claims
The company states Phytomem One ingredients are handled according to the USDA National Organic Program in a certified facility. This is a company claim this release could not independently verify, and should be treated accordingly. Consumers seeking batch-testing or quality documentation should request it directly from the company.
Availability
Phytomem One is sold in single- and multi-bottle configurations through the company’s official website, Pricing and refund terms should be confirmed directly on the official site.
Frequently Asked Questions
What ingredients does Phytomem One contain? Ten: Saffron Extract, Fucoxanthin, Fucoidan, Oleuropein, Berberine HCl, Ceylon Cinnamon Bark, Corosolic Acid, Kudzu Flower Extract, Morosil, and Xylitol, each disclosed individually rather than combined into a proprietary blend.
Does Phytomem One interact with medication? Yes, notably berberine. See Safety Considerations above; anyone taking diabetes medication or blood thinners should consult a physician before use.
Has Phytomem One been clinically tested as a finished product? No clinical trial of the finished ten-ingredient formula has been identified. Individual ingredients have independent research bases; that research does not establish the effect of the combined product.
How is Phytomem One taken? One tablet daily with food; serving instructions should be confirmed on current product labeling.
Does Phytomem One contain caffeine? The company describes the formula as stimulant-free. The ingredient list does not include caffeine-containing compounds.
Is Phytomem One formulated as a proprietary blend? No. The company states all ten ingredients are disclosed individually; consumers should consult the current Supplement Facts panel for exact quantities.
About Phytomem One
Founded in 2026, Phytomem One is a cognitive wellness supplement brand offering a 10-ingredient, once-daily capsule formulated to support memory, mental clarity, and brain health in adults. The product is manufactured in a USDA National Organic Program-certified facility and is available through the company’s direct-to-consumer platform and authorized retail partners. All purchases include a 60-day satisfaction guarantee.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Phytomem One contains berberine HCl, a pharmacologically active compound with documented drug interactions detailed in Safety Considerations above. Ingredient-level research cited in this release pertains to individual compounds studied independently and does not establish the safety or efficacy of the finished product. Consult a licensed healthcare professional before use. Individual results vary.
Rights and Permissions: All product names, marks, and trade dress referenced in this release are the property of their respective owners. Phytomem One and associated marks are trademarks of their respective owner. No third-party images, copyrighted text, or licensed content are reproduced in this release. All factual claims are attributed to named sources or identified as company representations. This release is issued by an affiliate partner and does not constitute medical advice. The affiliate link included in the Availability section is a commercial referral link; the issuing party may receive compensation if a purchase results.
This release does not include any third-party images. All trademarks referenced are the property of their respective owners.
Media Contact
Payton Williamson, Media Relations, Phytomem One
Email: support@getphytomemone.com
Phone: +1 (203) 872-9584
Address: 11870 62nd Street N, Largo, FL 33773
The post Phytomem One Reviews: Company Discloses Ten-Ingredient Cognitive Support Formula Targeting Microplastic Exposure and Brain Glucose Metabolism appeared first on 24 Health Times.
